FC
MEDP icon

Forte Capital’s Medpace MEDP Stock Holding History

Forte Capital’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$952K Sell
3,034
-20
-0.7% -$6K 0.1% 124
2025
Q1 		$931K Sell
3,054
-58
-2% -$19.5K 0.11% 121
2024
Q4 		$1.03M Sell
3,112
-125
-4% -$42.4K 0.12% 111
2024
Q3 		$1.08M Buy
3,237
+78
+2% +$29.6K 0.12% 112
2024
Q2 		$1.3M Buy
3,159
+181
+6% +$71.7K 0.16% 99
2024
Q1 		$1.2M Sell
2,978
-77
-3% -$27.1K 0.15% 100
2023
Q4 		$936K Sell
3,055
-80
-3% -$21.6K 0.13% 108
2023
Q3 		$759K Hold
3,135
– – 0.12% 109
2023
Q2 		$753K Buy
3,135
+20
+0.6% +$4.15K 0.11% 111
2023
Q1 		$586K Buy
3,115
+164
+6% +$33.9K 0.09% 122
2022
Q4 		$627K Buy
2,951
+271
+10% +$54.1K 0.11% 114
2022
Q3 		$421K Buy
2,680
+800
+43% +$128K 0.08% 134
2022
Q2 		$281K Buy
1,880
+610
+48% +$88.3K 0.05% 165
2022
Q1 		$276K Hold
1,270
– – 0.03% 197
2021
Q4 		$276K Buy
+1,270
New +$266K 0.03% 197

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Forte Capital's MEDP Position: Q2 2025 in Review

Forte Capital reduced its Medpace (MEDP) stake by 0.65% in Q2 2025, selling an estimated $6K and leaving 3,034 shares worth $952K. The position accounts for 0.1% of the portfolio, ranked #124.

Forte Capital first reported a position in MEDP in Q4 2021 and has held it in 15 quarters since. The position peaked at $1.3M in Q2 2024. 602 funds tracked by Wall St. Rank hold MEDP as of Q2 2025.

  • Forte Capital held 3,034 shares of Medpace worth $952K as of Q2 2025.
  • Forte Capital sold 20 Medpace shares in Q2 2025, an estimated $6K.
  • Medpace made up 0.1% of Forte Capital's portfolio in Q2 2025, its #124 holding.
  • Forte Capital first reported a position in Medpace in Q4 2021 and has held it in 15 quarters since.
  • Forte Capital's Medpace position peaked at $1.3M in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Medpace as of Q2 2025.

Based on Forte Capital's 13F filing for Q2 2025, filed 15 Jul 2025.